Published in Drug Saf on January 01, 2009
Duloxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.90
Intensive monitoring of duloxetine: results of a web-based intensive monitoring study. Eur J Clin Pharmacol (2012) 0.87
Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary. Drugs Context (2013) 0.87
Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder. J Psychiatry Neurosci (2015) 0.86
Using NMR approaches to drive the search for new CNS therapeutics. Curr Opin Investig Drugs (2010) 0.81
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder. Neuropsychiatr Dis Treat (2013) 0.79
The effect of initial duloxetine dosing strategy on nausea in korean patients with major depressive disorder. Psychiatry Investig (2012) 0.77
Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study. Psychiatry Investig (2016) 0.75
Efficacy comparison of duloxetine and SSRIs at doses approved in Japan. Neuropsychiatr Dis Treat (2015) 0.75
Continuation treatment of major depressive disorder: is there a case for duloxetine? Drug Des Devel Ther (2010) 0.75
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med (2009) 4.17
Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Intern Med (2007) 4.12
The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93
A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol (2006) 2.68
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med (2008) 2.65
Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.36
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med (2011) 2.31
Deployment and the use of mental health services among U.S. Army wives. N Engl J Med (2010) 2.21
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
The intersection of patient complexity, prescriber continuity and acute care utilization. J Gen Intern Med (2014) 1.90
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med (2006) 1.88
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med (2005) 1.83
The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol (2006) 1.82
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med (2011) 1.66
Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med (2013) 1.64
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med (2009) 1.41
Exploratory evaluation of medication classes most commonly involved in nursing home errors. J Am Med Dir Assoc (2012) 1.40
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry (2009) 1.38
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Saf (2008) 1.20
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS (2012) 1.18
Insomnia in patients with depression: a STAR*D report. CNS Spectr (2010) 1.18
Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis (2011) 1.17
Selected characteristics of senior citizens prescription drug payment and procurement in 1998 and 2001. J Manag Care Pharm (2003) 1.15
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry (2010) 1.13
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry (2011) 1.12
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol (2013) 1.11
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr (2005) 1.09
Diagnostic accuracy of Spanish language depression-screening instruments. Ann Fam Med (2009) 1.09
Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS (2012) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep (2012) 1.06
Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care (2007) 1.06
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol (2007) 1.03
Osteoporosis beliefs and antiresorptive medication use. Maturitas (2005) 1.02
Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry (2004) 1.01
Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry (2014) 1.01
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract (2007) 0.99
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev (2013) 0.98
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. J Clin Psychopharmacol (2012) 0.98
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol (2005) 0.97
Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents. Cochrane Database Syst Rev (2011) 0.97
Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. Eur J Cancer (2012) 0.96
Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults. Am J Geriatr Pharmacother (2005) 0.95
Physical activity and depressive symptoms among pregnant women: the PIN3 study. Arch Womens Ment Health (2010) 0.95
Medication errors during patient transitions into nursing homes: characteristics and association with patient harm. Am J Geriatr Pharmacother (2011) 0.93
Depressive symptoms among working women in rural North Carolina: a comparison of women in poultry processing and other low-wage jobs. Int J Law Psychiatry (2007) 0.93
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS (2013) 0.92
Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety (2012) 0.92
The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med (2010) 0.92
Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. J Clin Psychiatry (2007) 0.91
Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center. J Oncol Pharm Pract (2010) 0.91
Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry (2010) 0.91
Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics (2008) 0.90
Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol (2008) 0.90
Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci (2009) 0.89
Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatr Serv (2010) 0.89
Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health (2013) 0.89
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS (2015) 0.89
Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiol Drug Saf (2010) 0.89
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry (2007) 0.88
Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord (2012) 0.88
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv (2011) 0.88
Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. Psychiatr Serv (2011) 0.87
Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatr Serv (2012) 0.87
Evaluation of the Menopause-Specific Quality of Life Questionnaire: a factor-analytic approach. Menopause (2012) 0.86
Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Res Social Adm Pharm (2005) 0.86
Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003) (2009) 0.86
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract (2008) 0.86
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav (2014) 0.86
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev (2012) 0.85
Part D plan enrollment by uninsured medicare beneficiaries. Med Care (2010) 0.85
Predicting fatigue and depression in HIV-positive gay men. Psychosomatics (2002) 0.84
Ranking antidepressants. Lancet (2009) 0.84
Developing an expert panel process to refine health outcome definitions in observational data. J Biomed Inform (2013) 0.84
Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv (2010) 0.83
How should primary care doctors select which antidepressants to administer? Curr Psychiatry Rep (2012) 0.82
Relationship of clinical depression to periodontal treatment outcome. J Periodontol (2002) 0.82